Clinical trials
Stroke (CVA) or TIA clinical trials
Below are recruiting stroke (cva) or tia clinical trials, each written for real people, not researchers. We’re tracking 141 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07349121Recruiting
Testing the Farapulse and Watchman devices together
This trial is for people who need both a special heart treatment called pulsed field ablation (FARAPULSE) and a device to close off a small pouch in the heart (WATCHMAN FLX Pro or WATCHMAN FLX) to prevent strokes. The study will see how well both procedures work when done together.
AalstAges 18 years+ - NCT03452202Recruiting
Brain stimulation to improve speech after stroke
This trial studies whether gentle brain stimulation (tDCS) can improve speech after a stroke. It focuses on people with stroke-related apraxia of speech while carefully checking hearing, brain function, and safety with devices or metal.
New York, New YorkAges 18–99 - NCT04045665RecruitingPhase 3
Blood thinner vs usual care for new heart rhythm after bypass surgery
This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.
Little Rock, ArkansasAges 18 years+ - NCT04686253Recruiting
Study how a heart opening and its flow link to stroke
This study looks at the detailed flow pattern through a patent foramen ovale (PFO)—a small opening in the heart—and how it may relate to stroke, TIA, or migraine. Doctors use special ultrasound testing with contrast to better understand who is most affected.
Beijing, Beijing MunicipalityAges 16–65 - NCT04851886Recruiting
Vision tool to guide robot therapy for stroke arm posture
This trial tests a vision-based system that detects your arm and posture during robot-assisted upper-arm therapy after a prior stroke. It may help the robot guide treatment more safely and accurately based on your movements and positioning.
Charlestown, MassachusettsAges 18–80 - NCT04971564Recruiting
Blood inflammation test study in sudden brain oxygen loss
This trial looks at blood “inflammation-related” biomarkers to understand what happens early after certain sudden brain events. It may help doctors predict outcomes and tailor treatment for people like those with stroke types that sometimes need a clot-removal procedure.
Paris, Île-de-France RegionAges 18 years+ - NCT05028855Recruiting
Testing brain blood-flow control in recent carotid or MCA narrowing
This study tests how well your brain controls its own blood flow (“cerebral autoregulation”) after a recent TIA or ischemic stroke caused by a narrowed carotid or MCA artery. It may help researchers understand why symptoms happen and how to better assess brain circulation after stroke.
Changchun, JilinAges 18–80 - NCT05550077Recruiting
Imaging study for narrowed brain arteries after stroke
This trial uses a detailed eye/brain imaging test (optical coherence tomography) to study people with significantly narrowed brain arteries after certain stroke-like events. It may help researchers better understand and monitor this condition to improve care.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05885932Recruiting
Stent treatment versus medicines for blocked neck artery
This study compares a drug-coated stent placed in a neck (vertebral) artery versus best medical treatment with medicines and risk-factor control. It aims to reduce problems caused by a badly narrowed artery after recent stroke-like symptoms.
BeijingAges 18 years+ - NCT05951101Recruiting
Device to close an irregular heartbeat heart pocket safely
This trial tests the Zenith system, a device that seals off a heart area called the left atrial appendage to reduce stroke risk in people with atrial fibrillation (AF). You may be eligible if you have AF and a doctor recommends LAA closure, and you can return for follow-up scans and visits.
Parkville, VictoriaAges 18 years+ - NCT06014723Recruiting
Balloon angioplasty for recent minor stroke or TIA
This study tests a balloon procedure to open a narrowed artery in the brain to prevent further strokes. It is for people who recently had a mild stroke or high-risk TIA from a significant blockage.
Changchun, JilinAges 30–80 - NCT06108414RecruitingPhase 4
Low-dose vs standard-dose blood thinner for older adults with atrial fibrillation
This trial tests whether a lower dose of the blood thinner rivaroxaban works as well as the standard dose for people 70 and older with atrial fibrillation (an irregular heartbeat). The goal is to find the safest dose to prevent strokes while reducing bleeding risks.
Beijing, Beijing MunicipalityAges 70 years+ - NCT06601127RecruitingPhase 2
Tiprogrel for recent minor stroke or high-risk TIA
This trial tests a new anti-platelet drug called Tiprogrel to prevent another stroke in people who recently had a minor stroke or a transient ischemic attack (TIA) with certain artery narrowing or plaques. It aims to see if this medicine is safe and works better than current treatments.
Shenyang, LiaoningAges 40 years+ - NCT05147792Recruiting
LAA closure study for people with atrial fibrillation
This trial tests a non-drug procedure to close a heart area called the left atrial appendage (LAA) to help prevent stroke in people with atrial fibrillation who are high risk. It’s for people who want to avoid taking long-term blood thinners, though they may need short-term medication after the procedure.
Birmingham, AlabamaAges 18 years+ - NCT06869811Recruiting
Stroke prevention after failed blood thinners
This study is for people who had a stroke despite taking blood thinners for atrial fibrillation. It tests if adding a procedure to close the left atrial appendage (a small pouch in the heart) to your blood thinner is better than just taking the blood thinner alone to prevent another stroke.
Barcelona, BarcelonaAges 18–95 - NCT07185971Recruiting
Vision training system for chronic vision loss after brain injury
This study tests a device called PAVE that may help improve vision in people who have lost part of their sight due to stroke, brain injury, or brain surgery. It is for those with ongoing vision problems, not those with eye diseases.
Cedar Rapids, IowaAges 21–80 - NCT07196878Recruiting
Ultrasound-guided nerve stimulation to improve walking after stroke
This study tests a new, non-surgical treatment using ultrasound and gentle electrical stimulation (like a tiny pulse) to help improve walking after a stroke. It is for people who have had a stroke and are still working on their walking in physical therapy.
Zaragoza, AragonAges 18–70 - NCT07197996Recruiting
Stroke recovery trial testing an electrical nerve device
This trial is testing a small nerve stimulator device worn on the leg to see if it helps people recover walking ability after a stroke. It is for patients who cannot stand or walk on their own soon after a stroke caused by a blood clot.
Chester, CheshireAges 18 years+ - NCT07282041RecruitingPhase 2/Phase 3
A study on dulaglutide for brain artery narrowing after stroke
This trial tests if a once-weekly injection called dulaglutide (Trulicity) helps people with severe narrowing of a major brain artery after a minor stroke or TIA. The goal is to improve blood flow and reduce the risk of another stroke.
SingaporeAges 21–80 - NCT07430956RecruitingPhase 3
Stroke prevention in atrial fibrillation without standard blood thinners
This trial tests a new medication to prevent strokes and blood clots in people with atrial fibrillation (an irregular heartbeat) who cannot safely take standard blood thinners. The drug works by blocking a different clotting factor, which may lower bleeding risks.
Dothan, AlabamaAges 18 years+ - NCT07441382Recruiting
Comparing treatments for frail older adults with atrial fibrillation
This study tests whether combining a heart procedure (catheter ablation) with a device to close the left atrial appendage (LAAO) is safer or better than blood thinners alone for frail patients 75 years or older with atrial fibrillation and high stroke risk. It aims to find a treatment that reduces stroke while lowering bleeding risks.
Guangzhou, GuangdongAges 75 years+
Hear when a new Stroke (CVA) or TIA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for stroke (cva) or tia?
- Yes. Clin2 currently lists 141 recruiting stroke (cva) or tia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a stroke (cva) or tia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a stroke (cva) or tia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.